Please assess the completion status of the following clinical trial:

Trial Title: Inhaled Nitric Oxide Study for Respiratory Failure in Newborns

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Greater than 34 wks gestational age~* One or more of the following diagnoses: primary pulmonary hypertension of the newborn, respiratory distress syndrome, perinatal aspiration syndrome, pneumonia/sepsis, suspected pulmonary hypoplasia~* Oxygenation Index (OI) greater than 15 and less than 25 on 2 arterial blood gases at least 15 min apart~* Indwelling arterial line~* Echocardiography before randomization~* Parental consent~Exclusion Criteria:~* Congenital diaphragmatic hernia~* Known congenital heart disease~* Decision not to provide full therapy

- Gender: ALL
- Minimum Age: None
- Maximum Age: 14 Days
- Healthy Volunteers: f

Study Arms:
- Inhaled Nitric Oxide (Type: EXPERIMENTAL): Inhaled Nitric Oxide (iNO)
- Oxygen (Type: PLACEBO_COMPARATOR): 100% oxygen

Based on this trial design, predict the completion outcome and termination type (if applicable).